Related Experiment Videos

Impact of a structured intensive follow-up program on the control of hypertension in coronary patients--a randomized

Pedro S Mateus1, Nuno Bettencourt, Carla Costa Dias

  • 1Cardiology Department, Vila Nova de Gaia Hospital Centre, Vila Nova de Gaia, Portugal.

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|May 3, 2005
PubMed

Insights

A structured intensive follow-up program (SIFUP) improved blood pressure control in hypertensive coronary patients. This program led to significantly lower systolic and mean blood pressure compared to standard care.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Clinical Trials

Background:

  • Hypertension is a major cardiovascular risk factor.
  • Effective blood pressure control remains a challenge in many populations.
  • Coronary patients require optimized hypertension management strategies.

Purpose of the Study:

  • To evaluate the impact of a structured intensive follow-up program (SIFUP) on blood pressure control.
  • To assess the efficacy of SIFUP in patients with coronary artery disease.

Main Methods:

  • Prospective, randomized study of 237 acute coronary syndrome patients.
  • Assignment to either SIFUP (n=129) or general cardiology outpatient department (COD) (n=108).
  • Blind blood pressure assessment 9-18 months post-discharge; statistical analysis using chi-square and Student's t tests.

Main Results:

  • No significant difference in overall blood pressure target achievement between SIFUP and COD groups (57.5% vs. 48.5%).
  • Hypertensive patients in the SIFUP group showed significantly higher blood pressure control rates (44.8% vs. 24.2%, p=0.05).
  • SIFUP significantly reduced systolic (139.0 vs. 148.8 mmHg, p=0.04) and mean arterial pressure (98.7 vs. 103.9 mmHg, p=0.03).

Conclusions:

  • The structured intensive follow-up program (SIFUP) demonstrates effectiveness in managing hypertension among coronary patients.
  • SIFUP consistently resulted in a higher proportion of controlled blood pressure in hypertensive individuals within the study cohort.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...